• GSDMC and Pyroptosis-Based Risk Modeling in PAAD

  2026-08-27

  Yan et al. integrated pyroptosis-related gene expression, survival modeling, immune estimation, and drug-sensitivity prediction to define a prognostic framework for pancreatic adenocarcinoma. The study highlights GSDMC as a candidate therapeutic target and identifies PD.173074 among compounds warranting experimental follow-up, while emphasizing that the drug result is computational rather than clinical evidence.

• BODIPY 581/591 C11 for Cardiac Oxidative Stress

  2026-08-27

  Translate membrane lipid oxidation into a quantitative red-to-green fluorescence ratio with BODIPY 581/591 C11. This workflow is tailored to acute myocardial infarction models, helping researchers distinguish lipid peroxidation from broader reactive oxygen species signals and evaluate nanozyme or antioxidant interventions.

• Wnt/NR2F2 Drives Platinum Resistance in Brain Metastasis

  2026-08-26

  The reference study identifies a Wnt/NR2F2/GPX4 axis that enables lung cancer-derived brain metastatic cells to consume glutathione rapidly, suppress ferroptosis, and acquire platinum resistance. Its integrated metabolomics, proteomics, functional rescue, and transcriptional assays connect brain metastatic adaptation with a therapeutically relevant redox mechanism.

• Breast Cancer Dependence on MCL-1: Study Insights

  2026-08-26

  This study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic control of BAX/BAK-mediated mitochondrial cell death. Genetic deletion and pharmacological inhibition both restricted tumor growth, while additional data connected MCL-1 with breast cancer stem cell activity and tumor stemness markers.

• ABT-263 and the Hidden Biology of Caspase-3

  2026-08-25

  ABT-263 (Navitoclax) is best known as a potent Bcl-2 family inhibitor that exposes mitochondrial apoptotic dependencies. Its greater translational value may emerge when researchers connect that mechanism to the non-apoptotic biology of caspase-3, including cancer cell motility. This article presents a framework for using ABT-263 in apoptosis assays, cancer biology studies, resistance profiling, and migration-focused experiments without confusing apoptotic loss of viability with direct anti-motility activity.

• RIPostC, Ketone Bodies, and Ferroptosis in Stroke

  2026-08-25

  The 2024 ACS Chemical Neuroscience study identifies ketone body production as a mechanistic link between remote ischemic postconditioning and protection from ischemic stroke. Its rat and neuronal-cell experiments connect improved energy metabolism with reduced ferroptosis, offering a framework for testing defined ketone-body interventions in neuroprotection research.

• Sabutoclax Workflows for Apoptosis Profiling

  2026-08-24

  Sabutoclax is a membrane-permeable pan-Bcl-2 inhibitor suited to experiments that separate growth arrest from genuine cell killing. This practical guide pairs dose–response testing with time-resolved apoptosis measurements, mechanistic controls, and troubleshooting for cancer-cell and translational studies.

• Cefoperazone Sodium Salt: Assay Workflows

  2026-08-24

  Build more reproducible antimicrobial assays with Cefoperazone sodium salt by combining matrix-aware sample handling, species-stratified MIC testing, and resistance-focused controls. The workflow supports gram-negative resistance studies, comparative β-lactam profiling, and exploratory biliary tract infection research without treating one MIC result as a universal susceptibility claim.

• Sabutoclax: A Better Way to Read Apoptosis Assays

  2026-08-23

  Sabutoclax is a pan-Bcl-2 inhibitor suited to mechanistic cancer research, but its value depends on separating cytostasis from true cell killing. This article presents an assay interpretation framework that connects target engagement, apoptosis induction in cancer cells, and translational model selection.

• DeferoxamineB in Ferroptosis Research: Practical Workflows

  2026-08-22

  DeferoxamineB is an iron-chelation tool for separating iron-dependent lipid damage from copper-driven and metabolism-linked tumor cell death. This guide translates its chemistry into reproducible cell-culture workflows, controls, and troubleshooting strategies aligned with recent ferroptosis–cuproptosis research.

• ABT-263: Designing Better Apoptosis Assays

  2026-08-21

  ABT-263 and Navitoclax can do more than induce apoptosis: they can reveal whether a cancer model is primed, target-engaged, and competent to execute cell death. This guide connects Bcl-2 biology with rigorous assay design and a carefully bounded insight from synaptic signaling research.

• SCH772984 HCl: ERK1/2 Inhibitor Workflows

  2026-08-20

  SCH772984 HCl enables direct interrogation of ERK1/2 signaling, adaptive pathway reactivation, and treatment resistance in BRAF- and RAS-driven models. This workflow-focused guide connects rapid phospho-ERK pharmacodynamics with longer-term proliferation, resistance, and TERT-related assays.

• TCEP Hydrochloride in DPC Proteolysis Assays

  2026-08-20

  Tris(2-carboxyethyl) phosphine hydrochloride is more than a routine disulfide-reduction reagent. This article explains how controlled redox chemistry can improve interpretation of ubiquitin-dependent DNA-protein crosslink proteolysis assays while preserving broader biochemical utility.

• RIPostC, Ketone Bodies, and Ferroptosis in Stroke

  2026-08-19

  This 2024 ACS Chemical Neuroscience study identifies ketone body metabolism as a mechanistic link between remote ischemic postconditioning and reduced ferroptotic injury after ischemic stroke. Its combination of rat middle cerebral artery occlusion, neuronal oxygen-glucose deprivation/reoxygenation, erastin challenge, and metabolic and iron-related readouts provides a framework for testing ketone body signaling in neuroprotection.

• Nicotinamide Riboside Chloride in RGC Translation

  2026-08-19

  A translational framework for using Nicotinamide Riboside Chloride (NIAGEN) to connect NAD+ biology with stem cell-derived retinal ganglion cell models, while keeping differentiation evidence, metabolic hypotheses, and product specifications analytically separate.

8017 records 1/535 page Next 12345 下5页 Last page